0001428336 2026-06-26 2026-06-26 0001428336 1 2026-06-26 2026-06-26 shares iso4217:USD pure EX-FILING FEES 0001428336 N/A 0.0001381 S-8 S-8 HEALTHEQUITY, INC. false Equity Common Stock, par value $0.0001 per share true 2455000 84.795 208171725 28748.52 208171725 28748.52 0.00 28748.52 <div style="margin-top:12pt;padding-left:42.37pt;padding-right:2.77pt;text-align:justify;text-indent:-21.6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.12pt">Pursuant to Rule 416(a) under the Securities Act of 1933, as amended (the “</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline">Securities Act</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:120%">”), the registration statement on Form S-8 (the “</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline">Registration Statement</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:120%">”) to which this exhibit relates shall also cover any additional shares of common stock, par value $0.0001 per share (“</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline">Common Stock</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:120%">”) of HealthEquity, Inc. (the “</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline">Registrant</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:120%">”) that become issuable under the HealthEquity, Inc. Amended and Restated 2024 Equity Incentive Plan (the “</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline">Plan</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:120%">”) by reason of any stock dividend, stock split, recapitalization or other similar transaction.</span></div><div style="padding-left:42.37pt;padding-right:2.77pt;text-align:justify;text-indent:-21.6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.12pt">Represents 2,455,000 shares of Common Stock authorized for issuance under the Plan as a result of the increase to the share reserve approved by the Registrant’s stockholders on June 25, 2026.</span></div><div style="margin-bottom:12pt;padding-left:42.37pt;padding-right:2.77pt;text-align:justify;text-indent:-21.6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.12pt">Estimated solely for the purpose of calculating the amount of the registration fee pursuant to Rules 457(c) and 457(h) of the Securities Act, based on the average of the high and low sales prices of the Common Stock as reported on The NASDAQ Global Select Market on June 22, 2026.</span></div>